The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group study

Oncology Group ◽

Whole Abdominal Radiotherapy in the Adjuvant Treatment of Patients With Stage III and IV Endometrial Cancer: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70597-6 ◽

2006 ◽

Vol 2006 ◽

pp. 449-452

Author(s):

S.D. Yamada

Keyword(s):

Endometrial Cancer ◽

Adjuvant Treatment ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Abdominal Radiotherapy

Faculty Opinions recommendation of A phase II evaluation of nintedanib (BIBF-1120) in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.722006345.793527263 ◽

2017 ◽

Author(s):

Paola Gehrig

Keyword(s):

Endometrial Cancer ◽

Phase Ii ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Bibf 1120

Comparison of two intraoperative examination methods for the diagnosis of sentinel lymph node metastasis in clinically early stage endometrial cancer: A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-003)

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/j.ejogrb.2021.04.009 ◽

2021 ◽

Author(s):

Salih Taşkın ◽

Bulut Varlı ◽

Duygu Altın ◽

Özgüç Takmaz ◽

Doğan Vatansever ◽

...

Keyword(s):

Endometrial Cancer ◽

Lymph Node ◽

Early Stage ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Node Metastasis ◽

Examination Methods ◽

Early Stage Endometrial Cancer

71 The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: an israel gynecologic oncology group study

10.1136/ijgc-2019-igcs.71 ◽

2019 ◽

Author(s):

M Volodarsky ◽

A Namazov ◽

O Gemer ◽

L helpman ◽

N Hag-Yahia ◽

...

Keyword(s):

Endometrial Cancer ◽

Early Stage ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Oncological Safety ◽

Early Stage Endometrial Cancer

A Turkish Gynecologic Oncology Group study of fertility-sparing treatment for early-stage endometrial cancer

International Journal of Gynecology & Obstetrics ◽

10.1016/j.ijgo.2012.06.010 ◽

2012 ◽

Vol 119 (3) ◽

pp. 270-273 ◽

Cited By ~ 16

Author(s):

Polat Dursun ◽

Serkan Erkanli ◽

Ahmet Bariş Güzel ◽

Murat Gultekin ◽

Nefise Cagla Tarhan ◽

...

Keyword(s):

Endometrial Cancer ◽

Early Stage ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Fertility Sparing ◽

Early Stage Endometrial Cancer

A phase II evaluation of AZD6244, a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2013.04.086 ◽

2013 ◽

Vol 130 (1) ◽

pp. e12-e13 ◽

Cited By ~ 5

Author(s):

R. Coleman ◽

M. Sill ◽

P. Thaker ◽

K. De Geest ◽

D. Street ◽

...

Keyword(s):

Endometrial Cancer ◽

Phase Ii ◽

Gynecologic Oncology ◽

Oncology Group ◽

Limited access safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2016.04.038 ◽

2016 ◽

Vol 141 ◽

pp. 4-5 ◽

Cited By ~ 4

Author(s):

S.N. Westin ◽

M. Sill ◽

R.L. Coleman ◽

S.E. Waggoner ◽

K.N. Moore ◽

...

Keyword(s):

Endometrial Cancer ◽

Gynecologic Oncology ◽

Mek Inhibitor ◽

Oncology Group ◽

Akt Inhibitor ◽

Oncology Group Study ◽

Limited Access

Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.09.015 ◽

2009 ◽

Vol 112 (1) ◽

pp. 134-141 ◽

Cited By ~ 3

Author(s):

D. Scott McMeekin ◽

Joan L. Walker ◽

Ellen M. Hartenbach ◽

Michael A. Bookman ◽

Wui-Jin Koh

Keyword(s):

Radiation Therapy ◽

Endometrial Cancer ◽

High Risk ◽

Phase I ◽

Phase I Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Oncology Group ◽

Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5592 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5592-5592 ◽

Cited By ~ 2

Author(s):

Andrea P. Myers ◽

Virginia L. Filiaci ◽

Yuping Zhang ◽

Michael Pearl ◽

Kian Behbakht ◽

...

Keyword(s):

Endometrial Cancer ◽

Phase Ii ◽

Mutational Analysis ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Megestrol Acetate ◽

Oncology Group ◽

EP646 Could the long-term oncological safety of laparoscopic surgery in low risk endometrial cancer be also valid for the high intermediate and high-risk patients? A multi-center turkish gynecologic oncology group study conducted with 2745 endometrial cancer cases

10.1136/ijgc-2019-esgo.702 ◽

2019 ◽

Author(s):

MA Vardar ◽

AB Guzel ◽

S Taşkın ◽

M Güngör ◽

N Özgül ◽

...

Keyword(s):

Endometrial Cancer ◽

Laparoscopic Surgery ◽

High Risk ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Oncological Safety ◽

Risk Patients